• Zhengye Biotechnology received a Nasdaq notice citing non-compliance with the US$ 1 minimum bid price requirement.
• The deficiency followed 30 straight business days with a closing bid below US$ 1, spanning April 16 to May 28, 2026.
• Shares remain listed for now; the company has until Nov. 25, 2026 to regain compliance by closing at or above US$ 1 for 10 days.
• Failure to regain compliance by the deadline could trigger delisting risk; a reverse stock split is among options under review.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zhengye Biotechnology Holding Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-065272), on June 04, 2026, and is solely responsible for the information contained therein.